Pharmaceutical Technology Europe-05-01-2010

Pharmaceutical Technology Europe

Obtaining simultaneous multiple dissolution profiles of solid oral dosage formulations

May 01, 2010

Formulation

22

5

Testing the dissolution rates of a pharmaceutical formulation (also known as in vitro availability) aids drug quality control and is a compulsory requirement of the British, European and US pharmacopoeias.

Change is in the air for the European Clinical Trials Directive

May 01, 2010

Spotlight

22

5

Though many advantages are associated with the European Clinical Trials Directive, complexities have emerged since its introduction in 2004. Since 2007, efforts have been made to raise the issues and address the negative impact of the Directive.

The possibilities and challenges of spray drying

May 01, 2010

Ask the Expert

22

5

Why spray drying processes offer a range of particle engineering possibilities.

When and why should the pharmaceutical industry use NIR chemical imaging?

May 01, 2010

Special Feature

22

5

The author assesses the power and limitations of NIR chemical imaging and its future.

Change management: common failures and a checklist for improvement

May 01, 2010

Regulation

22

5

Though the pharma industry has improved its change management processes, there are still opportunities for improvement.

Bioanalysis: hurdles and hopes

May 01, 2010

Special Feature

22

5

Bioanalysis has migrated from a very general vocation to one that requires more specialization, particularly in GLP applications.

What do you think?

May 01, 2010

22

5

Over the last few months, we have been publishing a series of special features, which have sought to provide you with an overall view of current challenges, innovations and trends in niche pockets of the pharmaceutical industry.

Do emerging markets provide the answer to the pharmaceutical industry?

May 01, 2010

Manufacturing

22

5

The emerging markets represent an attractive investment opportunity for the pharmaceutical industry because of the countries' growing economies and unmet medical needs.

REACH: has the cloud of confusion cleared?

May 01, 2010

Manufacturing

22

5

The pharmaceutical industry must understand its responsibilities to improve the safety of chemicals as defined by the REACH initiative.